微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NeuroMetrix (NASDAQ:NURO) +65%
Reneo Pharmaceuticals (NASDAQ:RPHM) +25%
Neoleukin Therapeutics (NASDAQ:NLTX) +23%
InspireMD (NASDAQ:NSPR) +16%
Chembio Diagnostics (N...查看全文
$InspireMD(NSPR)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-22-000829 Act: 34 Size: 4 MB 网页链接
$InspireMD(NSPR)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-000554 Size: 7 KB 网页链接
$InspireMD(NSPR)$ 内部交易: 2021-12-28,Director,ROUBIN GARY S ,买入,16393普通股, $3.08
$InspireMD(NSPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-032757 Size: 6 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001493152-21-030697 Act: 34 Size: 7 MB 网页链接
$InspireMD(NSPR)$ 内部交易: 2021-12-01,Director,Stuka Paul ,买入,12037普通股, $3.51
$InspireMD(NSPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-030337 Size: 6 KB 网页链接
$InspireMD(NSPR)$ 内部交易: 2021-11-30,Director,Stuka Paul ,买入,18372普通股, $3.55
$InspireMD(NSPR)$ 内部交易: 2021-11-29,Director,Stuka Paul ,买入,3177普通股, $3.55
$InspireMD(NSPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-21-030119 Size: 8 KB 网页链接